Meet IA-Group Research Team at OARSI to Discuss Osteoarthritis Clinical Research
Meet IA’s musculoskeletal experts at the World Congress on Osteoarthritis in Las Vegas, NV, April 27-30, 2017, where they will be speaking about their work in osteoarthritis clinical research.
Dr. John Carrino, member of IA’s Clinical Advisory Board will speak at 12:00 on 30 April in a Plenary Session ‘Year in Review’ and give an overview of imaging in Osteoarthritis clinical practice and research.
The Chair of IA’s Clinical Advisory Board Dr. Mikael Boesen will present a paper linking the exercise and pain reductions in knee osteoarthritis. His presentation ‘Exercise-Induced Pain Reductions in Knee OA are Associated with Changes in Muscle Perfusion Quantified by Dynamic Contrast Enhanced MRI: Exploratory Outcome Analysis from a Randomized Controlled Trial’ is scheduled to start at 4:40pm on Saturday, 29 April.
Other collaborators of IA-Group from the Parker Institute, Nordic Bioscience, BICL and Boston University will be attending OARSI, which brings together the top researchers, investigators and investors trying to find cure for osteoarthritis.
Osteoarthritis is a degenerative joint disease and the most common disorder in the world. It is a result of a complex interplay of multiple factors, including joint integrity, genetic predisposition, local inflammation, mechanical forces and cellular and biochemical processes. There is no cure for OA at the moment.
IA-Group is a strategic partner to bio-pharmaceutical companies. We bring extensive therapeutic knowledge and regulatory expertise in strategic use of clinical imaging to enhance understanding of the mode of action, to increase the efficiency of clinical decisions and to accelerate drug development. IA‘s operations team leverage our global footprint and the next-generation cloud based propriety platform Dynamika to de-risk trial execution and to ensure data quality and integrity. Our venture arm pioneer unique targeted investment and risk-sharing models to enable our clients to reach the next value inflection point faster. We fuse decades of therapeutic insight and agile culture to meet today’s speed and high standard of therapeutic innovation.
T: + 44 74 13 02 20 53 / + 1 6177 523561